Trial Profile
A head-to-head comparison of Paclical with Abraxane in women with metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Apr 2023
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Pharmacokinetics
- Sponsors Oasmia Pharmaceutical
- 20 Aug 2019 Results published in the Advances in Therapy
- 05 Nov 2015 Final results published in an Oasmia Pharmaceutical media release.
- 05 Nov 2015 Status changed from active, no longer recruiting to completed, according to an Oasmia Pharmaceutical media release.